114450 — Green LifeScience Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Green LifeScience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3,136	-3,526	-16,358	1,562	110
Depreciation
Amortisation
Non-Cash Items	-1,428	247	12,157	-1,534	223
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	2,611	-4,042	2,095	-271	-759
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	611	-4,552	370	525	364
Capital Expenditures	-3,444	-1,478	-475	-463	-1,160
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,842	6,535	7,991	3,742	1,215
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-602	5,057	7,516	3,280	54.8
Financing Cash Flow Items	—	—	-2,031	-82	-127
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	961	-1,071	-4,307	-1,928	3,908
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	986	-574	3,533	2,720	4,339